Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Organon & Co. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 610
- −12 vs. Q4 2025
- Shares held
- 199.8M
- +39.0M (+24.3%) vs. Q4 2025
- Total value
- $1.20B
- +$45.7M (+4.0%) vs. Q4 2025
- New holders
- 81
- 134 more added
- Sold out
- 93
- 205 more reduced
14 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 636 | $2.92B |
| Q1 2026 | 610 | $1.20B |
| Q4 2025 | 636 | $1.43B |
| Q3 2025 | 672 | $2.13B |
| Q2 2025 | 697 | $2.07B |
| Q1 2025 | 722 | $3.01B |
| Q4 2024 | 741 | $3.07B |
| Q3 2024 | 726 | $3.81B |
| Q2 2024 | 727 | $4.11B |
| Q1 2024 | 720 | $3.75B |
| Q4 2023 | 720 | $2.85B |
| Q3 2023 | 733 | $3.45B |
| Q2 2023 | 728 | $4.13B |
| Q1 2023 | 769 | $4.67B |
| Q4 2022 | 823 | $5.57B |
| Q3 2022 | 793 | $4.57B |
| Q2 2022 | 855 | $6.56B |
| Q1 2022 | 822 | $6.65B |
| Q4 2021 | 911 | $5.49B |
| Q3 2021 | 934 | $5.67B |
| Q2 2021 | 995 | $5.27B |
| Q1 2021 | 1 | $103.0K |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Organon & Co.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Resources Management Corp | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Kohmann Bosshard Financial Services, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| IFC & Insurance Marketing, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Beddow Capital Management Inc | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| EMC Capital Management | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| Trust Co of Vermont | – | – | – | – | Not filed |
| ORG Partners LLC | – | – | – | – | Not filed |
| Maryland Capital Advisors Inc. | – | – | – | – | Not filed |
| Northwest Capital Management Inc | – | – | – | – | Not filed |
| Ransom Advisory, Ltd | – | – | – | – | Not filed |
| Motiv8 Investments LLC | – | – | – | – | Not filed |